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Methylmalonic  acidemia  with  emergency  hypertension
Acidemia  metilmalónica  con  hipertensión  de  emergencia-
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phy. Abdominal sonography was normal but both kidneys hadDear Editor,
Methylmalonic acidemia (MMA)  is a heterogeneous disor
der of propionate metabolism. MMA  is caused by deﬁcienc
of the mitochondrial enzyme, methylmalonyl-CoA mutase
apoenzyme activity (MUT) or defective in adenosylcobalamin
(coenzyme) synthesis.1 The most patients with cblA and hal
patients with cblB forms of MMA  are responsive to vitamin
B12.2,3 Clinical manifestation of MMA  may be acute or chronic
The acute form of the disease occurs during infancy and even
as early as the second day of life with poor feeding, vomiting
dehydration, weight loss, temperature instability, lethargy
hypotonia, seizure and progressing to coma. Laborator
ﬁndings include: metabolic acidosis, ketosis, hypoglycemia
hyperlactatemia, hyperammonemia, pancytopenia.4
Deﬁnitive diagnosis of isolated MMA  is based on analy
sis of organic acids in plasma and/or urine; however geneti
testing diagnosis in some condition is accessible to conﬁrm
the diagnosis of isolated MMA.  Below, we  describe the pre
sentation and management of two cases of MMA with sever
hypertention.
The ﬁrst case was a 46-day-old girl, admitted to the emer
gency department because of generalized edema and sever
hypertension. She was born from consanguineous parents a
term with a birth weight 2.600 kg. She had frequent vomi
ting in 9th day of life. Edema of hands and feet appeared in
39th day of life. On admission, she had SBP 130 mmHg  (abov
99th), DBP 75 mmHg  (above 99th), periorbital and legs pittin
edema and respiratory distress. Laboratory ﬁndings included
microscopic hematuria, massive proteinuria, hypoalbomine
mia, pancytopenia and high anion gap metabolic acidosis.
The patient was managed by nephrologists with diagnosis
of congenital nephrotic syndrome. Angiography of abdominal
aorta and renal artery were normal. She had brain atrophy
and supra and infra tentorial ventricolomegaly in brain
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emergency hypertension. Nefrologia. 2016;36:75–76.CT scan and left ventricular hypertrophy in echocardiogra
phy. Abdominal sonography was normal but both kidney
were seen larger than normal. Bone marrow aspiration
(BMA) was performed because of pancytopenia which wa
normal. Patient’s hypertension did not respond to Losartan
Hydralazine, Captopril and Amlodipine. Metabolic consulting
and then metabolic tests due to refractory metabolic acidosi
was done. The patient with suspected organic aciduria wa
treated with hydroxycobalamin 1 mg  daily, biotin 10 mg  daily
and l-carnitine 50 mg/kg/day. She had high level of glycine
in blood amino acid chromatography but ammonia, lactate
serum B12 and hemocystein were normal. Methylmalonic
aciduria conﬁrmed with high level of urine methlmalonic
acid and increased serum level of propionyl carnitine. We
have increased the dose of B12 up to 2 mg  IM daily bu
unfortunately, the patient died.
The second case was a 45-day-old boy admitted from
the emergency ward with complaints of anemia, respiratory
distress and severe hypertension. He was born from non
consanguineous parents at term with a birth weight 2.800 kg
The ﬁrst baby of the family had died at the age of 5-months due
to propionic aciduria. On examination he had respiratory dis
tress (RR = 67), SBP 134 mmHg  (above 99th) and DBP 78 mmHg
(above 99th) and mild pitting edema in legs. Laboratory result
included: high anion gap metabolic acidosis, pancytopenia
hypoalbominemia, proteinuria, and microscopic hematuria
Lactate, ammonia, serum B12, serum hemocystein and othe
electrolytes were normal but serum glycine was increased
Renal artery disorder has been excluded by Doppler sonograarib B, Bazargani B, Rezaei N, et al. Methylmalonic acidemia with
upper normal size and increased cortical echogenicity. BMA
was performed because of pancytopenia which was normal.
According to the familial history and our previous case, after
sending samples for urine organic acid, acylcarnitine proﬁle
and chromatography of serum amino acid, B12 2 mg  IM daily,
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carnitine 50 mg/kg/day, biotin 10 mg  daily and low protein diet
was started for the patient. His blood pressure was refrac-
tory to all of anti-hypertensive drugs such as Hydralazine,
Captopril, Labetalol. Methylmalonic aciduria conﬁrmed by
increased of urine methylmalonic acid and serum propionyl
carnitine. Despite early treatment of methylmalonic acid even
without waiting for tests result, the patient died.
Chronic renal disease is a life-threatening complication of
MMA  and ﬁnally leads to dialysis or kidney transplantation.
Renal impairment most occurs in patients with mut (0) and
cblB mutation.5 The mechanism of renal injury in MMA is
still unknown. Proximal tubular disorder is a main pathogenic
mechanism of MMA-associated kidney disease.6 A recent case
study has reported 2 cases of MMA  associated with hemolytic
uremic syndrome (HUS) association which revealed that prob-
able pathogenesis of thrombotic microangiopathy could be
related to the increase of plasma methylmalonic acid and
homocysteine levels.7
In the current study, the two mentioned patients had MMA
that conﬁrmed with assessment of urine organic acid and
acylcarnitine proﬁle. They had just renal involvement that
their symptom and signs were started during infancy that was
refractory to all of the treatment and despite early treatment
in the one of them, they died.
In summary, in each case with hematuria, proteinuria,
nephrotic syndrome, unexplained hypertension or renal fail-
ure of unknown origin especially in pediatric patients,
metabolic screening and urinary organic acid analysis should
be carried out as soon as possible.
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Necrotizing  glomerulonephritis  in levamisole-contaminated
cocaine use
Glomerulonefritis  necrosante  en  el  síndrome  por  consumo  de
cocaína  y  levamisol
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use of cocaine/levamisole (C/L), a syndrome distinguished
by
ec
th
thear Editor,
pain is the country with the greatest incidence of cocaine use
 adults,1,2 and consignments of levamisole-contaminated
caine has increased in the last decade.2,3 Regarding thePlease cite this article as: Sirvent AE, Enríquez R, Andrada E, Sánchez
ndrome por consumo de cocaína y levamisol. Nefrologia. 2016;36:76–78 the following has been reported: (1) purpuric, necrotic or
chymotic skin lesions on the trunk, limbs and earlobes;
e histological background is leukocytoclastic vasculitis or
rombotic vasculopathy; (2) leukopenia and neutropenia, and M, Millán I, González C. Glomerulonefritis necrosante en el
.
